Beta Bionics, Inc. Variable Lease, Cost
Beta Bionics, Inc. (BBNX) reported Variable Lease, Cost of $63.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2026-07-29
- Beta Bionics, Inc. variable lease, cost for the quarter ending 2026-06-30 was $63.00K, a 57.50% increase year-over-year.
- Beta Bionics, Inc. variable lease, cost for the quarter ending 2026-03-31 was $35.00K, a 20.45% decline year-over-year.
- Beta Bionics, Inc. variable lease, cost for the quarter ending 2025-12-31 was $49.00K, a 43.02% decline year-over-year.
- Beta Bionics, Inc. variable lease, cost for the quarter ending 2025-09-30 was $62.00K, a 19.23% increase year-over-year.
- Beta Bionics, Inc. variable lease, cost for fiscal 2025 was $195.00K, a 6.70% decline from fiscal 2024.
- Beta Bionics, Inc. variable lease, cost for fiscal 2024 was $209.00K, a 51.45% increase from fiscal 2023.
- Beta Bionics, Inc. variable lease, cost for fiscal 2023 was $138.00K.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 6 month | Variable Lease, Cost 9 month | Variable Lease, Cost 12 month |
|---|---|---|---|---|
| 2026-06-30 | $63.00K 10-Q · filed 2026-07-29 | $98.00K 10-Q · filed 2026-07-29 | $147.00K derived: sum of 3 quarters · filed 2026-07-29 | $209.00K derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | $35.00K 10-Q · filed 2026-04-21 | $84.00K derived: sum of 2 quarters · filed 2026-04-21 | $146.00K derived: sum of 3 quarters · filed 2026-04-21 | $186.00K derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-12-31 | $49.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $111.00K derived: sum of 2 quarters · filed 2026-02-24 | $151.00K derived: sum of 3 quarters · filed 2026-07-29 | $195.00K 10-K · filed 2026-02-24 |
| 2025-09-30 | $62.00K 10-Q · filed 2025-10-28 | $102.00K derived: sum of 2 quarters · filed 2026-07-29 | $146.00K 10-Q · filed 2025-10-28 | $232.00K derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | $40.00K 10-Q · filed 2026-07-29 | $84.00K 10-Q · filed 2026-07-29 | $170.00K derived: sum of 3 quarters · filed 2026-07-29 | $222.00K derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | $44.00K 10-Q · filed 2026-04-21 | $130.00K derived: sum of 2 quarters · filed 2026-04-21 | $182.00K derived: sum of 3 quarters · filed 2026-04-21 | $207.00K derived: sum of 4 quarters · filed 2026-04-21 |
| 2024-12-31 | $86.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $138.00K derived: sum of 2 quarters · filed 2026-02-24 | $163.00K derived: sum of 3 quarters · filed 2026-02-24 | $209.00K 10-K · filed 2026-02-24 |
| 2024-09-30 | $52.00K 10-Q · filed 2025-10-28 | $77.00K derived: sum of 2 quarters · filed 2025-10-28 | $123.00K 10-Q · filed 2025-10-28 | |
| 2024-06-30 | $25.00K 10-Q · filed 2025-07-29 | $71.00K 10-Q · filed 2025-07-29 | ||
| 2024-03-31 | $46.00K 10-Q · filed 2025-05-06 | |||
| 2023-12-31 | $138.00K 10-K/A · filed 2025-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |